

Ajovy (Fremanezumab) is an injectable CGRP inhibitor for migraine prevention. Learn about its uses, dosing options, cost, and what you need to know in 2026.
Ajovy (Fremanezumab-vfrm) is an injectable prescription medication used for the preventive treatment of migraine in adults and pediatric patients aged 12 and older.
Ajovy belongs to a class of drugs called CGRP inhibitors — calcitonin gene-related peptide inhibitors. It's a humanized monoclonal antibody manufactured by Teva Pharmaceuticals. The FDA first approved Ajovy in September 2018 for adult migraine prevention, and it has since been approved for adolescents aged 12 and older weighing at least 45 kg. Ajovy is not a controlled substance.
Unlike acute migraine treatments that stop an attack in progress, Ajovy is a preventive medication. It's designed to reduce the number of migraine days you experience each month before they happen. To understand how Ajovy works at a molecular level, see our mechanism of action guide.
Ajovy is FDA-approved for:
Ajovy is typically prescribed for patients who experience 4 or more migraine days per month and who may benefit from preventive therapy. It is not used to treat a migraine attack that has already started — for acute treatment, other medications like triptans or gepants are used.
Some healthcare providers prescribe Ajovy off-label for conditions including:
These uses are not FDA-approved, and evidence for them is still limited. Always discuss off-label use with your doctor.
Ajovy is given as a subcutaneous injection — a shot under the skin — in the abdomen, thigh, or upper arm. It comes in two forms:
You have two dosing options:
Both dosing schedules have been shown to be effective in clinical trials. The quarterly option is convenient for patients who prefer fewer injection days per year — just four sessions instead of twelve.
Your healthcare provider will train you on proper injection technique before your first self-administered dose.
Ajovy is contraindicated in patients with:
Additionally, use caution in these situations:
For a detailed look at potential reactions, read our guide to Ajovy side effects.
Ajovy is a brand-name biologic medication with no generic or biosimilar currently available. Here's what you can expect to pay:
For more details on reducing your costs, see our complete guide to saving money on Ajovy.
Ajovy is one of several CGRP-targeting medications available for migraine prevention. Here's a quick comparison:
Ajovy's unique advantage is its flexible dosing — you can choose between monthly and quarterly injections, both self-administered at home. For a deeper comparison, see our guide to alternatives to Ajovy.
Ajovy is a well-established, FDA-approved option for preventing migraines in adults and adolescents. With flexible monthly or quarterly dosing, a manageable side effect profile, and multiple savings programs available, it's a viable option for many migraine patients — especially those who haven't found relief with older preventive medications.
If you think Ajovy might be right for you, talk to a neurologist or headache specialist about whether it's a good fit. And if you need help finding it at a pharmacy, Medfinder can show you where it's in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.